期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 26, 期 2, 页码 243-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2012.03.010
关键词
Malaria; Plasmodium; Travel; Antimalarials
资金
- National Institute for Health Research [CL-2008-20-001] Funding Source: researchfish
Malaria remains the most important parasitic infection in humans. There have been significant advances in the treatment of both nonsevere and severe malaria with the advent of artemisinin combination therapies and parenteral artesunate, but the optimum supportive management of severe malaria is unclear. A broadly acceptable therapy for the prevention of relapses in Plasmodium vivax infection has not been discovered. Globally, the priority remains to prevent infection in the vulnerable, to move toward elimination where feasible, and to ensure that effective treatment is available to all. In developed settings, prevention of infection and its early recognition are crucial.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据